Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro Diagnostics

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1739285

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1739285

Tuberculosis Diagnostics

PUBLISHED:
PAGES: 284 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Tuberculosis Diagnostics Market to Reach US$2.6 Billion by 2030

The global market for Tuberculosis Diagnostics estimated at US$2.2 Billion in the year 2024, is expected to reach US$2.6 Billion by 2030, growing at a CAGR of 2.8% over the analysis period 2024-2030. Culture based Diagnosis, one of the segments analyzed in the report, is expected to record a 1.9% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Sputum Test segment is estimated at 3.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$601.4 Million While China is Forecast to Grow at 5.1% CAGR

The Tuberculosis Diagnostics market in the U.S. is estimated at US$601.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$500.3 Million by the year 2030 trailing a CAGR of 5.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.1% and 2.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.5% CAGR.

Global Tuberculosis Diagnostics Market - Key Trends & Drivers Summarized

Why Is Tuberculosis Still a Diagnostic Challenge in the 21st Century?

Despite being a preventable and curable disease, tuberculosis (TB) continues to pose a major public health challenge, especially in low- and middle-income countries. One of the biggest hurdles in the global fight against TB is the timely and accurate diagnosis of the disease, particularly among vulnerable populations such as children, people living with HIV, and individuals in remote or under-resourced areas. Traditional methods like sputum smear microscopy, though widely used, suffer from low sensitivity, especially in cases of extrapulmonary and latent TB. Moreover, the long turnaround time associated with culture methods and the limitations in infrastructure and skilled personnel in many endemic regions make advanced diagnostic solutions difficult to implement at scale. TB's variable clinical manifestations and similarities with other respiratory illnesses further complicate diagnosis, often leading to misdiagnosis or delayed treatment. These limitations underscore the urgent need for faster, more accurate, and accessible diagnostic technologies to help bridge the gap between infection and intervention.

How Are New Technologies Disrupting the Diagnostic Landscape for TB?

Recent years have seen an explosion in diagnostic innovations aimed at making TB detection faster, more accurate, and accessible. Molecular diagnostic tools, particularly nucleic acid amplification tests (NAATs) like GeneXpert and Truenat, have significantly improved the ability to detect TB and multidrug-resistant TB (MDR-TB) within hours. These point-of-care technologies are being deployed in field clinics and rural health centers, where they allow for rapid diagnosis without the need for complex lab infrastructure. In addition to NAATs, other breakthroughs such as interferon-gamma release assays (IGRAs) and TB LAM antigen tests are expanding diagnostic options, especially for people with HIV or in pediatric settings. Artificial intelligence is also being applied to enhance chest X-ray interpretation, while digital diagnostic platforms are improving sample tracking, data recording, and epidemiological mapping. The convergence of diagnostics with mobile health solutions enables remote consultations, follow-ups, and centralized decision-making, particularly valuable in countries with high TB burdens and fragmented healthcare systems.

Is the Global Push for Universal Health Coverage Influencing TB Diagnostic Access?

The global movement toward Universal Health Coverage (UHC) and the United Nations' End TB Strategy are exerting pressure on governments and international agencies to improve diagnostic access as a fundamental step toward eradication. Multilateral organizations like the WHO, Global Fund, and UNITAID are actively funding diagnostic tool development, procurement, and distribution, with a focus on affordability and scalability. National TB programs are being urged to integrate rapid molecular diagnostics into primary healthcare centers, making early detection more feasible and decentralized. In parallel, public-private partnerships are emerging to develop affordable diagnostic kits and local manufacturing capacities to overcome supply chain bottlenecks. However, diagnostic equity remains a challenge, with urban-rural disparities and affordability issues limiting reach. Some governments are adopting integrated disease testing platforms that combine TB testing with HIV, COVID-19, and hepatitis screening, which not only enhances detection but also improves healthcare system efficiency. These multi-disease testing frameworks are expected to drive increased uptake of TB diagnostics across high-risk populations.

What Is Driving Growth in the Tuberculosis Diagnostics Market?

The growth in the tuberculosis diagnostics market is driven by several factors, including the rising global TB incidence in densely populated and high-risk regions, increasing public health investments in infectious disease management, and rapid adoption of molecular diagnostic tools. End-use behavior, such as a growing preference for point-of-care testing in community clinics and mobile health units, is pushing the demand for portable, rapid diagnostics. Additionally, the emergence of drug-resistant TB strains has led to increased adoption of advanced molecular platforms capable of detecting resistance markers alongside TB pathogens. Funding from global health bodies and national governments is also accelerating the deployment of diagnostic tools, especially in endemic countries in Africa, Southeast Asia, and Eastern Europe. Technological trends such as multiplex testing, sample pooling, and automated result interpretation are further enhancing operational scalability. Consumer behavior is also shifting, with heightened awareness about TB symptoms and testing avenues post-COVID, making individuals more proactive in seeking early diagnosis - a factor that will continue to fuel diagnostic volumes globally.

SCOPE OF STUDY:

The report analyzes the Tuberculosis Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis, Other Types); End-Use (Hospitals, Diagnostic Labs, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • AdvaCare Pharma
  • Becton, Dickinson and Company (BD)
  • bioMerieux SA
  • Cepheid (Danaher Corporation)
  • DiaSorin S.p.A.
  • FIND (Foundation for Innovative New Diagnostics)
  • F. Hoffmann-La Roche AG
  • Hain Lifescience GmbH
  • Hologic, Inc.
  • JN-International Medical Corporation
  • Lionex GmbH
  • Lupin Limited
  • Novosibirsk TB Research Institute
  • Oxford Immunotec Ltd.
  • QIAGEN N.V.
  • R-Biopharm AG
  • Serum Institute of India Pvt. Ltd.
  • Thermo Fisher Scientific Inc.
  • Trivitron Healthcare

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

Show more
Product Code: MCP34450

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Tuberculosis Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Adoption of Rapid Molecular Testing Platforms Drives Early Detection and Case Management
    • Increasing Focus on Drug-Resistant TB Surveillance Strengthens Market Need for Genotypic Tools
    • Integration of AI in X-Ray Screening Expands Diagnostic Reach in Resource-Limited Settings
    • Public Health Funding and Global Donor Programs Propel Growth of Point-of-Care Diagnostics
    • Shift Toward Decentralized Testing Models Drives Demand for Portable and Compact Devices
    • Rising Co-Infection with HIV Accelerates Demand for Dual and Multiplex Testing Kits
    • Government Mandates for TB Case Notification Systems Spur Diagnostic Infrastructure Investments
    • Regulatory Approvals for Novel Antigen-Based Tests Expand Testing in Pediatric Populations
    • Expansion of Mobile and Remote Diagnostic Units Sustains Outreach in Rural Areas
    • Inclusion of TB Testing in Universal Health Coverage Expands Access and Market Size
    • Digital Reporting and Sample Tracking Platforms Drive Operational Efficiency in Testing Labs
    • Demand for Cost-Effective, High-Sensitivity Tools Creates Market Entry Opportunities for Local Players
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Tuberculosis Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Tuberculosis Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Tuberculosis Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Culture based Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Culture based Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Culture based Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Sputum Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Sputum Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Sputum Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Rapid Molecular Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Rapid Molecular Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Rapid Molecular Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostic Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Diagnostic Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Diagnostic Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Tuberculosis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Tuberculosis Diagnostics by Type - Percentage Breakdown of Value Sales for Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Tuberculosis Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Labs and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Tuberculosis Diagnostics by Type - Percentage Breakdown of Value Sales for Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Tuberculosis Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Labs and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Tuberculosis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Tuberculosis Diagnostics by Type - Percentage Breakdown of Value Sales for Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Tuberculosis Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Labs and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Tuberculosis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Tuberculosis Diagnostics by Type - Percentage Breakdown of Value Sales for Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Tuberculosis Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Labs and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Tuberculosis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Tuberculosis Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Tuberculosis Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Tuberculosis Diagnostics by Type - Percentage Breakdown of Value Sales for Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Tuberculosis Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Labs and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Tuberculosis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Tuberculosis Diagnostics by Type - Percentage Breakdown of Value Sales for Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Tuberculosis Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Labs and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Tuberculosis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Tuberculosis Diagnostics by Type - Percentage Breakdown of Value Sales for Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Tuberculosis Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Labs and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Tuberculosis Diagnostics by Type - Percentage Breakdown of Value Sales for Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Tuberculosis Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Labs and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Tuberculosis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Tuberculosis Diagnostics by Type - Percentage Breakdown of Value Sales for Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Tuberculosis Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Labs and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Tuberculosis Diagnostics by Type - Percentage Breakdown of Value Sales for Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Tuberculosis Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Labs and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Tuberculosis Diagnostics by Type - Percentage Breakdown of Value Sales for Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Tuberculosis Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Labs and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Tuberculosis Diagnostics by Type - Percentage Breakdown of Value Sales for Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Tuberculosis Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Labs and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Tuberculosis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Tuberculosis Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Tuberculosis Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Tuberculosis Diagnostics by Type - Percentage Breakdown of Value Sales for Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Tuberculosis Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Labs and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Tuberculosis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Tuberculosis Diagnostics by Type - Percentage Breakdown of Value Sales for Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Tuberculosis Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Labs and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Tuberculosis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Tuberculosis Diagnostics by Type - Percentage Breakdown of Value Sales for Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Tuberculosis Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Labs and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Tuberculosis Diagnostics by Type - Percentage Breakdown of Value Sales for Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Tuberculosis Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Labs and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Tuberculosis Diagnostics by Type - Percentage Breakdown of Value Sales for Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Tuberculosis Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Labs and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Tuberculosis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Tuberculosis Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Tuberculosis Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Tuberculosis Diagnostics by Type - Percentage Breakdown of Value Sales for Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Tuberculosis Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Labs and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Tuberculosis Diagnostics by Type - Percentage Breakdown of Value Sales for Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Tuberculosis Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Labs and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Tuberculosis Diagnostics by Type - Percentage Breakdown of Value Sales for Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Tuberculosis Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Labs and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Tuberculosis Diagnostics by Type - Percentage Breakdown of Value Sales for Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Tuberculosis Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Labs and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Tuberculosis Diagnostics by Type - Percentage Breakdown of Value Sales for Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Tuberculosis Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Labs and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Tuberculosis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Tuberculosis Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Tuberculosis Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Tuberculosis Diagnostics by Type - Percentage Breakdown of Value Sales for Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Tuberculosis Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Labs and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Tuberculosis Diagnostics by Type - Percentage Breakdown of Value Sales for Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Tuberculosis Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Labs and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Tuberculosis Diagnostics by Type - Percentage Breakdown of Value Sales for Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Tuberculosis Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Labs and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Tuberculosis Diagnostics by Type - Percentage Breakdown of Value Sales for Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Tuberculosis Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Labs and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Tuberculosis Diagnostics by Type - Percentage Breakdown of Value Sales for Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Tuberculosis Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Labs and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Tuberculosis Diagnostics by Type - Percentage Breakdown of Value Sales for Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Tuberculosis Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Labs and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Tuberculosis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Tuberculosis Diagnostics by Type - Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Tuberculosis Diagnostics by Type - Percentage Breakdown of Value Sales for Culture based Diagnosis, Sputum Test, Rapid Molecular Diagnosis and Other Types for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Tuberculosis Diagnostics by End-Use - Hospitals, Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Tuberculosis Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Labs and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!